---
title: "Irritable Bowel Syndrome: Interactive Clinical Guide"
slug: "irritable-bowel-syndrome-interactive"
date: "2025-09-20"
tags: ["gastroenterology", "IBS", "interactive-guide", "evidence-based"]
description: "Fully illustrated, interactive guide for healthcare professionals on IBS diagnosis and management."
lang: ["en"]
---

import Image from 'next/image';
import { Tabs, TabList, Tab, TabPanel, Collapse } from '@chakra-ui/react'; 

# Irritable Bowel Syndrome (IBS)

Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder with altered motility, visceral hypersensitivity, and mucosal permeability. Diagnosis is clinical using **Rome IV criteria**, and management focuses on symptom control.

---

## Epidemiology

<Collapse title="Click to expand Epidemiology">
- **Prevalence:** 10–20% in North America and Europe; 20–50% of gastroenterology referrals. [1]  
- **Sex:** Women 1.5–2× more affected.  
- **Age:** 20–39 years highest prevalence.  
- **Associated conditions:** Fibromyalgia, chronic fatigue syndrome, depression, anxiety, GERD, functional dyspepsia. [2][3]
</Collapse>

---

## Pathophysiology

<Collapse title="Click to expand Pathophysiology">
IBS is **functional**, with no organic cause. Common features include:  

- Altered GI motility  
- Visceral hypersensitivity  
- Mucosal permeability changes  
- Psychosocial factors [4][5]  

<Image src="/images/ibs-pathophysiology.png" alt="IBS Pathophysiology" width={600} height={400} />
</Collapse>

---

## Clinical Features

<Collapse title="Click to expand Clinical Features">
- **Abdominal pain:** Chronic, diffuse, relieved by defecation  
- **Bowel habits:** Diarrhea, constipation, or alternating  
- **Other GI symptoms:** Nausea, bloating, mucus  
- **Extraintestinal:** Fatigue, dysmenorrhea, urinary urgency  
- **Physical exam:** Usually normal  
</Collapse>

---

## IBS Subtypes

<Tabs variant="enclosed" colorScheme="teal">
  <TabList>
    <Tab>IBS-D (Diarrhea)</Tab>
    <Tab>IBS-C (Constipation)</Tab>
    <Tab>IBS-M (Mixed)</Tab>
    <Tab>IBS-U (Unclassified)</Tab>
  </TabList>

  <TabPanel>
    <p>Diarrhea is predominant. Consider loperamide, rifaximin, or specialized 5-HT3/ opioid modulators.</p>
    <Image src="/images/ibs-d.png" alt="IBS-D" width={600} height={400} />
  </TabPanel>
  <TabPanel>
    <p>Constipation predominant. Consider PEG, tenapanor, or tegaserod.</p>
    <Image src="/images/ibs-c.png" alt="IBS-C" width={600} height={400} />
  </TabPanel>
  <TabPanel>
    <p>Alternating diarrhea and constipation. Management is tailored to predominant symptom at each episode.</p>
    <Image src="/images/ibs-m.png" alt="IBS-M" width={600} height={400} />
  </TabPanel>
  <TabPanel>
    <p>Unclassified IBS: criteria met but stool pattern cannot be categorized.</p>
    <Image src="/images/ibs-u.png" alt="IBS-U" width={600} height={400} />
  </TabPanel>
</Tabs>

---

## Diagnosis

<Collapse title="Click to expand Diagnosis">
### Rome IV Criteria
- Symptoms ≥6 months  
- Recurrent abdominal pain ≥1 day/week for past 3 months  
- ≥2 of: pain related to defecation, stool frequency change, stool form change [7]  

### Labs & Investigations
- CBC for all  
- Diarrhea: fecal calprotectin, CRP, celiac serology, giardiasis stool test  
- Consider thyroid and infectious tests as indicated  

### Colonoscopy
- Only with **red flags** or routine CRC screening [8]  

<Image src="/images/ibs-diagnosis-flow.png" alt="IBS Diagnosis Flowchart" width={700} height={500} />
</Collapse>

---

## Differential Diagnoses

<Collapse title="Click to expand Differentials">
| Condition | Appearance | Pain | Stool |
|-----------|-----------|------|-------|
| IBS | Healthy; no weight loss | Relieved by defecation; diffuse; no nighttime pain | Diarrhea/constipation; no blood |
| Crohn | Weight loss | Constant RLQ, nocturnal | Watery diarrhea, nocturnal possible |
| UC | Weight loss in severe cases | LLQ, nocturnal | Bloody diarrhea with mucus |
| Colorectal CA | Weight loss | Often painless | R-sided: melena/diarrhea; L-sided: constipation |

**Red flags:** Nighttime diarrhea, fever, blood in stool, weight loss, acute onset  
Other differentials: gastroenteritis, thyroid disorders, celiac disease, lactose intolerance, SIBO
</Collapse>

---

## Treatment

<Collapse title="Click to expand Nonpharmacological">
- **Diet:** Soluble fiber, avoid triggers, low FODMAP (with dietitian)  
- **Lifestyle:** Exercise, stress management  
- **Psychobehavioral:** CBT, hypnotherapy  
- **Adjunctive:** Peppermint oil [8][10]
</Collapse>

<Collapse title="Click to expand Pharmacotherapy">
**Diarrhea:** Loperamide, rifaximin, alosetron, eluxadoline  
**Constipation:** PEG, tenapanor, tegaserod  
**Abdominal pain:** Antispasmodics (dicyclomine, hyoscyamine), tricyclic antidepressants (amitriptyline)  
**Refractory:** Gastroenterology referral [8][11][12]
</Collapse>

---

## Disposition

- Usually managed outpatient  
- Educate on alarm features and return precautions  

---

## References

1. Wilkins T, et al. *Am Fam Physician*. 2012;86(5):419–426.  
2. Chey WD, et al. *JAMA*. 2015;313(9):949–958.  
3. Canavan C, et al. *Clin Epidemiol*. 2014;6:71–80.  
4. Camilleri M, et al. *Am J Physiol*. 2012;303(7):775–785.  
5. Thabane M, Marshall JK. *World J Gastroenterol*. 2009;15(29):3591–3596.  
6. Camilleri M. *JAMA*. 2021;325(9):865.  
7. Lacy BE, et al. *Gastroenterology*. 2016;150(6):1393–1407.e5.  
8. Lacy BE, et al. *Am J Gastroenterol*. 2020;116(1):17–44.  
9. Smalley W, et al. *Gastroenterology*. 2019;157(3):851–854.  
10. Moayyedi P, et al. *J Can Assoc Gastroenterol*. 2019;2(1):6–29.  
11. Lembo A, et al. *Gastroenterology*. 2022;163(1):137–151.  
12. Chang L, et al. *Gastroenterology*. 2022;163(1):118–136.  
13. Walls R, et al. *Rosen's Emergency Medicine*, 10th Edition, 2022.  
